Hôpital Saint-André

Running trials

• Not yet recruiting

  Carboplatin-Enhanced Therapy in BRCA-Mutated or Neuroendocrine-Differentiated Aggressive Metastatic Castration-Sensitive Prostate Cancer

  NCT07591467· Phase 3· Gustave Roussy, Cancer Campus, Grand Paris· Source

• Not yet recruiting

  CABOTEGRAVIR/LENACAPAVIR DUAL LONG ACTING THERAPY (COHORT IMEA 074)

  NCT07402044· Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba· Source

• Recruiting

  ANRS0392s ELDORADO : Phase III, open-label, randomized, multicenter trial EvaLuating the non-inferiority of DORAvirine versus DOlutegravir based antiretroviral regimens in treatment-naïve people living with HIV-1 infection

  NCT06203132· Phase 3· Inserm· Source

• Recruiting

  THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension

  NCT06559891· SoniVie Inc.· Source

• Active, not recruiting

  Durvalumab Plus Etoposide-free Chemotherapy in First-line Treatment of Extensive-disease Small-sell Lung Cancer (SCLC)

  NCT05856695· Phase 2· Intergroupe Francophone de Cancerologie Thoracique· Source

• Recruiting

  A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

  NCT05208762· Phase 1· Seagen, a wholly owned subsidiary of Pfizer· Source

• Enrolling by invitation

  Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia Areata

  NCT03976622· University Hospital, Bordeaux· Source

• Active, not recruiting

  The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension

  NCT03614260· ReCor Medical, Inc.· Source

• Active, not recruiting

  ESTIMation of the ABiLity of Prophylactic Central Compartment Neck Dissection to Modify Outcomes in Low-risk Differentiated Thyroid Cancer

  NCT03570021· Phase 3· Gustave Roussy, Cancer Campus, Grand Paris· Source

• Active, not recruiting

  A Study of Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer

  NCT03473743· Phase 1/2· Janssen Research & Development, LLC· Source

• Active, not recruiting

  Risk of Morbidity, Mortality and Long-term Monitoring of Antiretroviral Treatment in People Living With HIV

  NCT03296202· University Hospital, Bordeaux· Source

• Not yet recruiting

  Evaluation study of a treatement with Nivolumab and Ipilimumab or tKi according to molecular group in naïve metastatic Kidney cancer

  NCT02960906· Phase 2· ARTIC· Source

• Active, not recruiting

  Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma

  NCT00005584· Phase 3· European Organisation for Research and Treatment of Cancer - EORTC· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• HIV2 recruiting
• Alopecia areata1 recruiting
• Atopic dermatitis (eczema)1 recruiting
• Endometrial cancer1 recruiting
• Gastric and oesophageal cancer1 recruiting
• Head and neck cancer1 recruiting
• High blood pressure1 recruiting
• Kidney cancer1 recruiting
• Liver and biliary tract cancer1 recruiting
• Lung cancer1 recruiting
• Pancreatic cancer1 recruiting
• Prostate cancer1 recruiting
• Psoriasis1 recruiting
• Triple-negative breast cancer1 recruiting
• Vitiligo1 recruiting

Closed trials

• Completed

  Biosensors for Open and Closed-loop Glycemia Control in T1D Patients With Insulin Pump

  NCT04081883· University Hospital, Bordeaux· Source

• Completed

  National Epidemiological Study of the Possible Impact of Stress on Glycaemic Control in Patients With Type 1 Diabetes

  NCT06365255· Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète· Source

• Completed

  Aging With HIV and Neurocognitive Decline, a Follow-up Study

  NCT05385588· ANRS, Emerging Infectious Diseases· Source

• Terminated

  Defining the Role of the Skin Microbiome in Immune-related Adverse Events

  NCT04734704· University Hospital, Bordeaux· Source

• Completed

  First In Human Study With ABBV-CLS-579 When Given Alone and In Combination In Participants With Locally Advanced Or Metastatic Tumors

  NCT04417465· Phase 1· AbbVie· Source

• Completed

  A Study of Erdafitinib in Participants With Advanced Solid Tumors and Fibroblast Growth Factor Receptor (FGFR) Gene Alterations

  NCT04083976· Phase 2· Janssen Research & Development, LLC· Source

• Recruiting

  Observation of Clinical Routine Care for Patients With BIOTRONIK Implantable Cardiac Monitors (ICMs)

  NCT04075084· Biotronik SE & Co. KG· Source

• Completed

  Efficacy and Safety of Dupilumab Chronic Hands Eczema Refractory to Highly Potent Topical Corticosteroids

  NCT03861455· Phase 2· University Hospital, Toulouse· Source

• Completed

  SIKAMIC (SIklos on Kidney Function and AlbuMInuria Clinical Trial)

  NCT03806452· Phase 2· Theravia· Source

• Completed

  Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302)

  NCT03260894· Phase 3· Incyte Corporation· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Vitiligo15 works · 2 trials